Valuation

LGNDLigand Pharmaceuticals Inc

StockNasdaqEstados UnidosHealth careEU retail: available

−2,8% today · +63,0% over a year

6/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 79% of the instruments we score

No dividend.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricLGNDSector medianvs median
P/E29,828,8 · n=114near the median
P/B6,13,0 · n=197101% above
P/S20,23,8 · n=203439% above
EV/EBIT59,624,1 · n=103148% above
Free-cash-flow yield2,2%2,7% · n=18818% below
Dividend yield0,00%0,00% · n=216—
Return on equity22,0%2,4% · n=194814% above
Return on invested capital7,2%3,4% · n=177113% above
Gross margin—62,5% · n=152—
Net debt / EBITDA−1,811,19 · n=108252% below

Value factor: 45 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42,633,6—1,6%0,6%6/10
JNJJohnson & Johnson29,17,2—3,6%2,1%8/10
ABBVAbbVie79,9—33,53,6%3,0%5/10
MRKMerck114,68,7—4,4%2,3%8/10
UNHUnitedHealth25,13,418,66,7%2,3%9/10
TMOThermo Fisher Scientific35,74,735,22,9%0,3%8/10
AMGNAmgen26,319,724,04,4%2,3%6/10
GILDGILEAD—16,1—6,8%2,1%4/10
ABTAbbott28,53,426,84,1%3,0%5/10
PFEPfizer38,42,0—6,6%5,9%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 jun. 2026 · filed 07 ago. 2026